Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.
about
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageThe perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionMembrane attack by complement: the assembly and biology of terminal complement complexesLate and chronic antibody-mediated rejection: main barrier to long term graft survivalThe importance of C4d in biopsies of kidney transplant recipientsUnraveling the Role of Allo-Antibodies and Transplant InjuryAntibody therapy can enhance AngiotensinII-induced myocardial fibrosis.Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredientComplement activation in astrocytomas: deposition of C4d and patient outcomeGenotypic diversity of complement component C4 does not predict kidney transplant outcomeAntibodies in transplantation.Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation.Antibody-mediated rejection: an evolving entity in heart transplantation.An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLAPathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction.Modulators of complement activation: a patent review (2008 - 2013).Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.Plasma levels of complement factor I and C4b peptides are associated with HIV suppression.Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory.Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.Activation of Complement by Pigment Epithelium-Derived Factor in Rheumatoid Arthritis.Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection.Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.
P2860
Q26778646-731C64E7-392D-4976-9066-59B68DA85D37Q26862195-BCA40D89-C20A-4E5E-9C81-55CC24954609Q26997385-0CC18A96-45C3-403D-B4E2-095B4D604798Q27006030-3A4B8C5A-ECF4-4390-B32F-4487399696BEQ27021227-B44ABB0F-BC69-4ED7-9538-7A4D0AB0AFA3Q28069336-40D9F319-DA5F-492B-A010-5C44D59E689EQ33614147-9C6A3365-63AF-4809-82E6-5063D921264FQ33622902-A4FE2AD4-8390-493E-A796-3EF6BAD8C460Q34496822-216B005D-9F4D-4FDA-A0AF-B40D93753B14Q34534928-2C6D4105-9B79-419C-8E91-DC69C3F23100Q34667057-030295EE-7913-4B74-BBAA-A82789FC57ABQ34901573-D118FACD-CD29-4617-B821-BB8EF649E7BEQ35876250-A95B11B2-B79A-4858-8D95-4C83B28413DCQ36302476-E7C69621-B2D2-45A3-856F-4C8E6FC0D550Q37228867-D6A99CA7-7F97-45D7-9A20-77802F730893Q37414746-C0E910AA-E33A-48CF-B9AB-D2F47C29FCA8Q38196860-B01226C8-C5AC-4536-AA47-4525E9C0953AQ38787427-A5480490-CF8B-40B0-9E9E-8E02632965B0Q39097599-8A4C1953-E914-4515-84DE-2B566D127458Q40061486-7CD8CA6E-8FC3-476D-97B8-B9E88D2134CBQ40979777-1881874C-0B2A-4664-8236-1B20FB6B406EQ41966451-1B645032-64DD-4694-A3F3-33479FE394FFQ47133994-BD8640BC-6873-49A7-8495-04735AF098F9Q48215946-AA485AB4-5F38-47F0-B920-EB1851011125Q48241059-0642EE7B-4F94-41BE-A0A4-5C0D19859E8AQ49297064-8DB81DEF-B0E5-456E-B072-B75EF1C77A72Q53656379-1A79C1B6-1E09-48AB-B5AD-4DA9BD04DCBB
P2860
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of complement activ ...... f antibody-mediated rejection.
@en
Mechanisms of complement activ ...... f antibody-mediated rejection.
@nl
type
label
Mechanisms of complement activ ...... f antibody-mediated rejection.
@en
Mechanisms of complement activ ...... f antibody-mediated rejection.
@nl
prefLabel
Mechanisms of complement activ ...... f antibody-mediated rejection.
@en
Mechanisms of complement activ ...... f antibody-mediated rejection.
@nl
P2860
P1476
Mechanisms of complement activ ...... f antibody-mediated rejection.
@en
P2093
Kazunori Murata
William M Baldwin
P2860
P304
P356
10.1016/J.TRRE.2009.02.005
P577
2009-04-10T00:00:00Z